CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
About this item
Full title
Author / Creator
Advani, Ranjana , Flinn, Ian , Popplewell, Leslie , Forero, Andres , Bartlett, Nancy L , Ghosh, Nilanjan , Kline, Justin , Roschewski, Mark , LaCasce, Ann , Collins, Graham P , Tran, Thu , Lynn, Judith , Chen, James Y , Volkmer, Jens-Peter , Agoram, Balaji , Huang, Jie , Majeti, Ravindra , Weissman, Irving L , Takimoto, Chris H , Chao, Mark P and Smith, Sonali M
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
An antibody to CD47 used in combination with rituximab induced responses in half of a small group of patients with refractory B-cell lymphoma. Inhibiting the macrophage checkpoint overcame rituximab resistance by activating macrophage-mediated tumor phagocytosis.
Alternative Titles
Full title
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Authors, Artists and Contributors
Author / Creator
Flinn, Ian
Popplewell, Leslie
Forero, Andres
Bartlett, Nancy L
Ghosh, Nilanjan
Kline, Justin
Roschewski, Mark
LaCasce, Ann
Collins, Graham P
Tran, Thu
Lynn, Judith
Chen, James Y
Volkmer, Jens-Peter
Agoram, Balaji
Huang, Jie
Majeti, Ravindra
Weissman, Irving L
Takimoto, Chris H
Chao, Mark P
Smith, Sonali M
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8058634
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8058634
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1807315
